Cargando…
Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
We have recently published on the limited effectiveness of sirolimus as a treatment option for hypoglycaemia as a consequence of hyperinsulinism. Our data oppose the view that mTOR inhibitors provide new opportunities for the treatment of patients with hyperinsulinism. We are not convinced by the ar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391606/ https://www.ncbi.nlm.nih.gov/pubmed/28410602 http://dx.doi.org/10.1186/s13023-017-0621-5 |